Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Stephane Supiot"'
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
Externí odkaz:
https://doaj.org/article/a2a6bf377b864a4280c065493209a6a9
Autor:
Robert G. Bristow, Anne E. Kiltie, Stephane Supiot, Jane Ran, Shahnaz AL Rashid, Farid Jalali, Helen Zhao, Ananya Choudhury
RAD51 is a key protein in the homologous recombination (HR) pathway of DNA double-strand break repair, and HR represents a novel target for cancer therapy. Because imatinib (Gleevec) has been reported to reduce RAD51 protein levels, we tested the clo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::014f1c676183a67af076abd54143313c
https://doi.org/10.1158/1535-7163.c.6531600
https://doi.org/10.1158/1535-7163.c.6531600
Autor:
Robert G. Bristow, Anne E. Kiltie, Stephane Supiot, Jane Ran, Shahnaz AL Rashid, Farid Jalali, Helen Zhao, Ananya Choudhury
Supplementary Fig. S1 from Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6116f62fd8e71d1595840967a2178a81
https://doi.org/10.1158/1535-7163.22484829
https://doi.org/10.1158/1535-7163.22484829
Autor:
Maureen Labbé, Manon Chang, Benjamin Saintpierre, Franck Letourneur, Laurence de Beaurepaire, Joëlle Véziers, Sophie Deshayes, Marine Cotinat, Jean-François Fonteneau, Christophe Blanquart, Vincent Potiron, Stéphane Supiot, Delphine Fradin
Publikováno v:
Cell Death and Disease, Vol 15, Iss 10, Pp 1-12 (2024)
Abstract Radiotherapy represents a major curative treatment for prostate cancer (PCa), but some patients will develop radioresistance (RR) and relapse. The underlying mechanisms remain poorly understood, and miRNAs might be key players in the acquisi
Externí odkaz:
https://doaj.org/article/0fc0b34f43f243738215274c3fef238f
Autor:
Nicolas Benziane, Thomas Zilli, Antoine Giraud, Gianluca Ingrosso, Mario Di Staso, Fabio Trippa, Emmanuel Meyer, Giulio Francolini, Ulrike Schick, Jean Marc Cosset, Etienne Martin, Victoria Ferrari, Vérane Achard, Nicolas Giraud, Corentin Pasquier, Inga Mihoci, null Beatrice Detti, Hind Zaine, Pascal Pommier, Osman Osman, Tanguy Perennec, Khemara Gnep, Nicolas Magné, David Pasquier, Stephane Supiot, Paul Sargos
Publikováno v:
Journal of Urology. 207
Autor:
Chloé Dupraz, Coline Ducrot, Benoit Allignet, Gregory Delpon, Anthony Alexis, Ariane Lapierre, Stéphane Supiot, David Ali, Max Piffoux
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 48, Iss , Pp 100834- (2024)
Background: The major drivers of carbon dioxide (CO2eq) emissions of external beam radiation therapy (EBRT) are not well known and limit our ability to initiate mitigation strategies. Material and methods: We describe the carbon footprint of four typ
Externí odkaz:
https://doaj.org/article/5a1069a33784488ca0a19ae68f21e3ba
Autor:
Loic Mourey, Helen Jane Boyle, Guilhem Roubaud, Raymond S. McDermott, Stephane Supiot, Bertrand F. Tombal, Aude Flechon, Dominik R. Berthold, Philippe Ronchin, Gabriel Kacso, Jean Francois Berdah, Fabio Calabro, Gwenaelle Gravis, Samuel Palumbo, Thierry Gil, Brigitte Vie, Hélène Ribault, Karim Fizazi, Stéphanie Foulon, Joan Carles
Publikováno v:
Journal of Clinical Oncology. 41:20-20
20 Background: Metastatic castration-sensitive prostate cancer (mCSPC) primarily affects older men (OM). In this post-hoc analysis we investigated the safety and efficacy of abiraterone acetate + prednisone (AAP) in older (≥ 70 years) and younger (
Autor:
Alan Dal Pra, Stephane Supiot, Katrin Gysel, Thomas Zilli, Richard Cathomas, Thomas Reynaud, Pascal Pommier, Paul Martin Putora, Davide Giovanni Bosetti, Matthias Guckenberger, Guido Hildebrandt, Sabrina Chiquet, Meryem Brihoum, Alexandros Papachristofilou, Stefanie Hayoz, Pirus Ghadjar, Daniel Rudolf Zwahlen, Silke Gillessen, Aurelius Gabriel Omlin, Daniel M. Aebersold
Publikováno v:
Journal of Clinical Oncology. 41:353-353
353 Background: Pre-clinical and retrospective clinical data support an interaction of metformin (MET) and radiotherapy. Thus, MET may represent a cost-effective means to improve radiotherapy outcomes. We sought to investigate whether MET increases t
Autor:
Tanguy Perennec, Maximilien Rogé, Jean-François Hetet, Philippe Colls, Valentine Guimas, Emmanuel Rio, Loïg Vaugier, Stéphane Supiot
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract Cryotherapy is an ablative therapy that can be used to treat localized prostate cancer. In case of recurrence, treatment options are not well-defined, and their outcomes are unknown. We therefore collected all patients treated with radiother
Externí odkaz:
https://doaj.org/article/6387c7b1be4840b79089f9da4a193898
Autor:
Antonin Levy, Daphné Morel, Matthieu Texier, Roger Sun, Jerome Durand-Labrunie, Maria E Rodriguez-Ruiz, Severine Racadot, Stéphane Supiot, Nicolas Magné, Stacy Cyrille, Guillaume Louvel, Christophe Massard, Loic Verlingue, Fanny Bouquet, Alberto Bustillos, Lisa Bouarroudj, Clément Quevrin, Céline Clémenson, Michele Mondini, Lydia Meziani, Lambros Tselikas, Rastilav Bahleda, Antoine Hollebecque, Eric Deutsch
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-13 (2024)
Abstract Background Immuno-radiotherapy may improve outcomes for patients with advanced solid tumors, although optimized combination modalities remain unclear. Here, we report the colorectal (CRC) cohort analysis from the SABR-PDL1 trial that evaluat
Externí odkaz:
https://doaj.org/article/e2332711ee644fd79fb6e8ed2a5b6190